Source: Celgene Corp.Biotech companies have been among the market’s best-performing stocks, and that means many of the industry’s top stocks have soared to lofty levels that might have kept investors on the sidelines. Since sliding markets are likely to take biotech stocks lower, investors could soon have their first chance in a long time to buy into some great companies […]
In what looks like a sequel to March 2014, high-flying biotechnology stocks and exchange traded funds are retreating amid talk of frothy valuations and a biotech bubble.At least temporarily, Friday March 20 marked the top for several of the largest biotech ETFs. That is when big-name ETFs, such as the iShares Nasdaq Biotechnology ETF (IBB) , the largest biotech ETF, […]
GILD Stock Continues Recovery From Monday’s FallGilead Sciences, Inc. (NASDAQ: GILD)GILD stocks fell hard Monday; losing more than two percent as the company issued a warning to doctors treating their patients with Sovaldi in combination with antiarrhythmics. However, the slide stopped and the stock started to move in the positive direction. Today, it seems as though the stock is staying […]
The financial markets have been on the rise for the past six years. That can only mean that doom is around the corner. What financial bubble is waiting to pop, and destroy us? Today: biotech stocks.What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, […]
The financial markets have been on the rise for the past six years. That can only mean that doom is around the corner. What financial bubble is waiting to pop, and destroy us? Today: biotech stocks.What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, and When Will it Pop? What Is the Next Bubble, […]
It’s been an eventful week on the pipeline front with companies like Biogen (BIIB – Analyst Report), Prothena (PRTA – Snapshot Report) and Vertex (VRTX – Analyst Report) coming out with data. Meanwhile, Gilead (GILD – Analyst Report) was back in the news once again due to its hepatitis C virus (HCV) franchise.Recap of the Week’s Most Important Stories1. Hopes […]
NEW YORK (MarketWatch) — U.S. stocks fell on Wednesday, declining for the third straight session, as a selloff in technology and biotech stocks pushed indexes lower.The S&P 500 SPX, -0.88% lost 19.06 points, or 0.9%, to 2,072.44. Technology stocks were hit hard, with the largest company on the index, Apple Inc. dropping more than 1%.The Dow Jones Industrial Average DJIA, […]
Everyone likes a great deal, and there’s no biotech stock I’d love to see go on sale more than Celgene (NASDAQ: CELG).Celgene’s blockbuster drugs, industry-leading profitability, and rock-solid balance sheet put it among the elite companies in the business. As a result, the company hasn’t given investors too many chances to buy its shares at a bargain price. But if […]
Here’s how to protect your profits in biotech: Trader
Susquehanna’s Stacey Gilbert thinks biotech could be due for a pullback. She lays out an options strategy to protect your biotech holdings.
It’s been a record-breaking run for biotech stocks, with the Nasdaq Biotech ETF, the IBB, up 18 percent this year alone and nearly 300 percent in the past five years. But […]
Stocks came in again on Tuesday, after a morning bounce, still consolidating after last weeks gains. Trading volume was again light. Leading stocks continue to hold their own and now include biotechs, midcaps and small caps. I had buy signals on speculative stocks ABMD, OVAS, and DPLO – none of which I bought. Both ABMD and DPLO gave no safe […]
